Zhou Xinda

1 month ago | caixinglobal.com | Zhou Xinda |Lu Zhenhua

00:00/00:00 您的浏览器不支持 audio 标签。 Listen to this article 1x China’s top legislature has approved a revised law on infectious disease prevention and control, aimed at bolstering the nation’s public health defenses while seeking to better protect individual rights during outbreaks. The updated law will take effect on Sept. 1. The National People’s Congress (NPC) voted to pass the amendments to the Infectious Disease Prevention and Control Law on April 30.

1 month ago | caixinglobal.com | Zhou Xinda |Qing Na

As Beijing focuses on spurring domestic consumption amid mounting external pressures, researchers view strengthening its social security system as crucial, with low-income groups and workers hurt by U.S. tariffs key areas to provide support. “Low- and middle-income groups should be at the core of the efforts in stimulating consumption,” Zhou Hong, a member of the Chinese Academy of Social Sciences (CASS), said at a seminar Saturday.

2 months ago | caixinglobal.com | Tang Hanyu |Zhou Xinda |Qing Na

Explore the story in 3 minutes[para. 1] In China, local governments have prioritized subsidizing various social insurance programs, including basic pensions and medical insurance. However, this initiative has put a significant strain on already financially burdened local budgets, prompting predictions that individuals may have to assume more responsibility for funding these programs. [para. 2][para.

2 months ago | caixinglobal.com | Tang Hanyu |Zhou Xinda |Qing Na

Explore the story in 3 minutes[para. 1] In China, local governments have prioritized subsidizing various social insurance programs, including basic pensions and medical insurance. However, this initiative has put a significant strain on already financially burdened local budgets, prompting predictions that individuals may have to assume more responsibility for funding these programs. [para. 2][para.

Feb 10, 2025 | caixinglobal.com | Kelly Wang |Zhou Xinda

00:00/00:00 您的浏览器不支持 audio 标签。 Listen to this article 1x China’s national health insurance and medicine regulators have defended the quality of drugs procured through the country’s central bulk-buying program, rebutting claims from medical professionals earlier this year that some of the medications had been less effective than advertised.